Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mounjaro in familial partial lipodystrophy
NCT07091734Phase 2Recruiting
- Sponsor
- University of Michigan
- Start
- Sep 2025
- Primary completion
- Sep 2029
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in familial partial lipodystrophy (FPLD), sponsored by University of Michigan. Started Sep 2025; status: recruiting.
02
Drugs
03
Conditions
familial partial lipodystrophy (FPLD)
Beyond the preview
Go deeper on NCT07091734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07091734.